AstraZeneca is a global, innovation-driven, biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. With Veeva CRM, AstraZeneca’s US Medical Affairs team has realized a return on investment of 29%, saving the pharmaceutical leader 30% annually.